| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2013 | A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. | Zhu, J; Zhou, L; Wu, G; Konig, H; Lin, X; Li, G; Qiu, XL; Chen, CF; Hu, CM; Goldblatt, E; Bhatia, R; Chamberlin, AR; Chen, PL; Lee, WH | EMBO Molecular Medicine 5(3):353-65 | | | |
| 2015 | Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. | Hu, CM; Zhu, J; Guo, XE; Chen, W; Qiu, XL; Ngo, B; Chien, R; Wang, YV; Tsai, CY; Wu, G; Kim, Y; Lopez, R; Chamberlin, AR; Lee, EY; Lee, WH | Oncogene 34(10), 1220-30 | | | |
| 2014 | Novel small molecules disrupting Hec1/Nek2 interaction ablates tumor progression by triggering Nek2 degradation through a death-trap mechanism. | Hu, CM; Zhu, J; Guo, XE; Chen, W; Qiu, XL; Ngo, B; Chien, R; Wang, YV; Tsai, CY; Wu, G; Kim, Y; Lopez, R; Chamberlin, AR; Lee, EH; Lee, WH | ONCOGENE 1-11 | | | |
| 2015 | Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors. | Zhu, J; Chen, H; Guo, XE; Qiu, XL; Hu, CM; Chamberlin, AR; Lee, WH | European journal of medicinal chemistry 96, 196-208 | | | |
